▶ 調査レポート

薬剤溶出ステントの世界市場:市場規模、シェア、成長、動向、予測

• 英文タイトル:Drug-eluting Stents Market (Product: Polymer-based and Polymer-free; Drug: Sirolimus, Everolimus, Paclitaxel, Zotarolimus, Biolimus, and Others; Generation: 1st Generation, 2nd Generation, 3rd Generation, and 4th Generation: Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, and Others; Application: Coronary Diseases and Peripheral Vascular Diseases; End User: Hospitals and Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。薬剤溶出ステントの世界市場:市場規模、シェア、成長、動向、予測 / Drug-eluting Stents Market (Product: Polymer-based and Polymer-free; Drug: Sirolimus, Everolimus, Paclitaxel, Zotarolimus, Biolimus, and Others; Generation: 1st Generation, 2nd Generation, 3rd Generation, and 4th Generation: Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, and Others; Application: Coronary Diseases and Peripheral Vascular Diseases; End User: Hospitals and Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / TPM-NV039資料のイメージです。• レポートコード:TPM-NV039
• 出版社/出版日:Transparency Market Research / 2019年10月22日
• レポート形態:英文、PDF、256ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥602,680 (USD5,795)▷ お問い合わせ
  Multi User¥914,680 (USD8,795)▷ お問い合わせ
  Global Site License¥1,226,680 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、薬剤溶出ステントの世界市場について調べ、薬剤溶出ステントの世界市場規模、市場動向、市場シェア、市場環境、市場予測、製品別(ポリマーベースおよびポリマーフリー)分析、薬物別(シロリムス、エベロリムス、パクリタキセル、ゾタロリムス、バイオリムス、その他)分析、世代別(第1世代、第2世代、第3世代、および第4世代)分析、スカフォード別(コバルト-クロム、プラチナ-クロム、ニチノール、生分解性、その他)分析、関連企業情報などをまとめました。
・薬剤溶出ステントの市場概要
・薬剤溶出ステントの市場動向
・薬剤溶出ステントの世界市場規模・予測
・薬剤溶出ステント市場:製品別(ポリマーベースおよびポリマーフリー)
・薬剤溶出ステント市場:薬物別(シロリムス、エベロリムス、パクリタキセル、ゾタロリムス、バイオリムス、その他)
・薬剤溶出ステント市場:薬物別(シロリムス、エベロリムス、パクリタキセル、ゾタロリムス、バイオリムス、その他)
・薬剤溶出ステント市場:スカフォード別(コバルト-クロム、プラチナ-クロム、ニチノール、生分解性、その他)
・地域別分析(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争環境・関連企業分析

Drug-eluting Stents Market – Scope of the Report

[256 Pages Report] The latest research from Transparency Market Research offers a perspective on the growth trajectory of drug-eluting stents market for the period of 2019-2027. The prime objective of this report is to provide insights and key dynamics pertaining to the drug-eluting stents market that are gradually helping reimagine its future development prospects.

Key growth indicators of the drug-eluting stents market, including historical value and volume analysis, pricing analysis, value and supply chain analysis, and Y-o-Y growth trend analysis have been elucidated in the report. Readers can avail unbiased analysis and in-depth information on the drug-eluting stents market that can help them estimate both, qualitative and quantitative growth prospects of the market for the given timeframe.

TMR covers a detailed taxonomy of the drug-eluting stents market, along with an incisive outlook on the competitive scenario. The report profiles a list of companies operating in the drug-eluting stents market, wherein, the product portfolios, technological innovations, geographical expansion, and key growth strategies of these players have been mentioned in detail.

The report on the drug-eluting stents market allows stakeholders to understand key demand trends that end users may seek in the long run, and the appropriate sourcing strategy for the same. For companies involved in the drug-eluting stents market, the report helps understand key end users contributing to demand, allowing them to strategically formulate steps to enhance their sales prospects.

Key Questions Answered in the Drug-eluting Stents Market Report

Elaborate insights provided in the drug-eluting stents market report address various questions to help stakeholders gain a deeper understanding and take critical decisions with confidence and clarity. Some of these questions include:

What is the consumption rate of the products based on geographical division?
Which trends and barriers will impact the development and sizing of the drug-eluting stents market?
What growth momentum or acceleration does the drug-eluting stents market carry during the forecast period?
Which region may tap the highest market share in the next five years?
What focused approach and constraints are holding the drug-eluting stents market tight?
What are the general conditions prevailing and influencing the business environment of the drug-eluting stents market?
How have leading players in the drug-eluting stents market been able to maintain a distinct competitive edge over their competitors?
Research Methodology

The drug-eluting stents market report is a result of unique research methodology, which includes a perfect combination of primary research, secondary research, and expert panel reviews. The data repository for the drug-eluting stents market is updated on a continuous basis, with key stakeholders and their developments tracked at regular intervals.

Secondary sources such as annual reports, company websites, industry white papers, government publications, investor presentations, statistical databases, internal and external proprietary databases, and regulatory databases are generally referred to for developing preliminary market understanding.

Primary research involves interviews and e-mail interactions with C-level executives, KOLs, and regional officers of companies operating in the drug eluting stents market, for unbiased, yet detailed reviews on the drug-eluting stents market across different geographical divisions.

Information obtained from secondary resources and verified by primary resources have contributed to the compilation of the drug-eluting stents market report.

Drug-eluting Stents Market – Segmentation

The report provides an all-inclusive segmental analysis of the global drug-eluting stents market, which has been classified into seven broader categories – product, drug, generation, scaffold, application, end user, and region.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Drug-eluting Stents Market
3.1. Market Overview
3.2. Introduction
3.3. Product Definition
3.4. Industry Evolution / Developments
4. Overview
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Global Drug-eluting Stents Market Analysis and Forecast, 2017–2027
5. Key Insights
5.1. Breakthrough Technologies in Drug-eluting Stents Market
5.2. Regulatory Approvals in Drug-eluting Stents Market
5.3. Strategic Approaches by Market Players (Acquisitions, Partnerships, and Distribution Agreements, etc.)
5.4. Product Launch
6. Global Drug-eluting Stents Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Drug-eluting Stents Market Value Forecast, by Product, 2017–2027
6.3.1. Polymer-based
6.3.1.1. Biodegradable Polymers
6.3.1.2. Durable Polymers
6.3.2. Polymer-free
6.4. Global Drug-eluting Stents Market Attractiveness, by Product
7. Global Drug-eluting Stents Market Analysis and Forecast, by Drug
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Drug-eluting Stents Market Value Forecast, by Drug, 2017–2027
7.3.1. Sirolimus
7.3.2. Paclitaxel
7.3.3. Zotarolimus
7.3.4. Everolimus
7.3.5. Biolimus
7.3.6. Others
7.4. Global Drug-eluting Stents Market Attractiveness, by Drug
8. Global Drug-eluting Stents Market Analysis and Forecast, by Generation
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Drug-eluting Stents Market Value Forecast, by Generation, 2017–2027
8.3.1. 1st Generation
8.3.2. 2nd Generation
8.3.3. 3rd Generation
8.3.4. 4th Generation
8.4. Market Attractiveness, by Generation
9. Global Drug-eluting Stents Market Analysis and Forecast, by Scaffold Type
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Global Drug-eluting Stents Market Value Forecast, by Scaffold Type, 2017–2027
9.3.1. Cobalt Chromium
9.3.2. Platinum Chromium
9.3.3. Nitinol
9.3.4. Biodegradable
9.3.5. Others
9.4. Global Drug-eluting Stents Market Attractiveness, by Scaffold Type
10. Global Drug-eluting Stents Market Analysis and Forecast, by Application
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Global Drug-eluting Stents Market Value Forecast, by Application, 2017–2027
10.3.1. Coronary Diseases
10.3.2. Peripheral Vascular Diseases
10.4. Global Drug-eluting Stents Market Attractiveness, by Application
11. Global Drug-eluting Stents Market Analysis and Forecast, by End-user
11.1. Introduction & Definition
11.2. Key Findings / Developments
11.3. Global Drug-eluting Stents Market Value Forecast, by End-user, 2017–2027
11.3.1. Hospitals
11.3.2. Ambulatory Surgical Centers
11.4. Global Drug-eluting Stents Market Attractiveness, by End-user
12. Global Drug-eluting Stents Market Analysis and Forecast, by Region
12.1. Key Findings
12.2. Global Drug-eluting Stents Market Value Forecast, by Region
12.2.1. North America
12.2.2. Europe
12.2.3. Asia Pacific
12.2.4. Latin America
12.2.5. Middle East & Africa
12.3. Global Drug-eluting Stents Market Attractiveness, by Country/Region
13. North America Drug-eluting Stents Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. North America Drug-eluting Stents Market Value Forecast, by Product, 2017–2027
13.3.1. Polymer-based
13.3.1.1. Biodegradable Polymers
13.3.1.2. Durable Polymers
13.3.2. Polymer-free
13.4. North America Drug-eluting Stents Market Value Forecast, by Drug, 2017–2027
13.4.1. Sirolimus
13.4.2. Paclitaxel
13.4.3. Zotarolimus
13.4.4. Everolimus
13.4.5. Biolimus
13.4.6. Others
13.5. North America Drug-eluting Stents Market Value Forecast, by Generation, 2017–2027
13.5.1. 1st Generation
13.5.2. 2nd Generation
13.5.3. 3rd Generation
13.5.4. 4th Generation
13.6. North America Drug-eluting Stents Market Value Forecast, by Scaffold Type, 2017–2027
13.6.1. Cobalt Chromium
13.6.2. Platinum Chromium
13.6.3. Nitinol
13.6.4. Biodegradable
13.6.5. Others
13.7. North America Drug-eluting Stents Market Value Forecast, by Application, 2017–2027
13.7.1. Coronary Diseases
13.7.2. Peripheral Vascular Diseases
13.8. North America Drug-eluting Stents Market Value Forecast, by End-user, 2017–2027
13.8.1. Hospitals
13.8.2. Ambulatory Surgical Centers
13.9. North America Drug-eluting Stents Market Value Forecast, by Country, 2017–2027
13.9.1. 1. U.S.
13.9.2. Canada
13.10. North America Drug-eluting Stents Market Attractiveness Analysis
13.10.1. By Product
13.10.2. By Drug
13.10.3. By Generation
13.10.4. By Scaffold Type
13.10.5. By Application
13.10.6. By End-user
13.10.7. By Country
14. Europe Drug-eluting Stents Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Europe Drug-eluting Stents Market Value Forecast, by Product, 2017–2027
14.3.1. Polymer-based
14.3.1.1. Biodegradable Polymers
14.3.1.2. Durable Polymers
14.3.2. Polymer-free
14.4. Europe Drug-eluting Stents Market Value Forecast, by Drug, 2017–2027
14.4.1. Sirolimus
14.4.2. Paclitaxel
14.4.3. Zotarolimus
14.4.4. Everolimus
14.4.5. Biolimus
14.4.6. Others
14.5. Europe Drug-eluting Stents Market Value Forecast, by Generation, 2017–2027
14.5.1. 1st Generation
14.5.2. 2nd Generation
14.5.3. 3rd Generation
14.5.4. 4th Generation
14.6. Europe Drug-eluting Stents Market Value Forecast, by Scaffold Type, 2017–2027
14.6.1. Cobalt Chromium
14.6.2. Platinum Chromium
14.6.3. Nitinol
14.6.4. Biodegradable
14.6.5. Others
14.7. Europe Drug-eluting Stents Market Value Forecast, by Application, 2017–2027
14.7.1. Coronary Diseases
14.7.2. Peripheral Vascular Diseases
14.8. Europe Drug-eluting Stents Market Value Forecast, by End-user, 2017–2027
14.8.1. Hospitals
14.8.2. Ambulatory Surgical Centers
14.9. Europe Drug-eluting Stents Market Value Forecast, by Country/Sub-region, 2017–2027
14.9.1. Germany
14.9.2. U.K.
14.9.3. France
14.9.4. Spain
14.9.5. Italy
14.9.6. Rest of Europe
14.10. Europe Drug-eluting Stents Market Attractiveness Analysis
14.10.1. By Product
14.10.2. By Drug
14.10.3. By Generation
14.10.4. By Scaffold Type
14.10.5. By Application
14.10.6. By End-user
14.10.7. By Country/Sub-region
15. Asia Pacific Drug-eluting Stents Market Analysis and Forecast
15.1. Introduction
15.2. Key Findings
15.3. Asia Pacific Drug-eluting Stents Market Value Forecast, by Product, 2017–2027
15.3.1. Polymer-based
15.3.1.1. Biodegradable Polymers
15.3.1.2. Durable Polymers
15.3.2. Polymer-free
15.4. Asia Pacific Drug-eluting Stents Market Value Forecast, by Drug, 2017–2027
15.4.1. Sirolimus
15.4.2. Paclitaxel
15.4.3. Zotarolimus
15.4.4. Everolimus
15.4.5. Biolimus
15.4.6. Others
15.5. Asia Pacific Drug-eluting Stents Market Value Forecast, by Generation, 2017–2027
15.5.1. 1st Generation
15.5.2. 2nd Generation
15.5.3. 3rd Generation
15.5.4. 4th Generation
15.6. Asia Pacific Drug-eluting Stents Market Value Forecast, by Scaffold Type, 2017–2027
15.6.1. Cobalt Chromium
15.6.2. Platinum Chromium
15.6.3. Nitinol
15.6.4. Biodegradable
15.6.5. Others
15.7. Asia Pacific Drug-eluting Stents Market Value Forecast, by Application, 2017–2027
15.7.1. Coronary Diseases
15.7.2. Peripheral Vascular Diseases
15.8. Asia Pacific Drug-eluting Stents Market Value Forecast, by End-user, 2017–2027
15.8.1. Hospitals
15.8.2. Ambulatory Surgical Centers
15.9. Asia Pacific Drug-eluting Stents Market Value Forecast, by Country/Sub-region, 2017–2027
15.9.1. China
15.9.2. Japan
15.9.3. India
15.9.4. Australia & New Zealand
15.9.5. Rest of Asia Pacific
15.10. Asia Pacific Drug-eluting Stents Market Attractiveness Analysis
15.10.1. By Product
15.10.2. By Drug
15.10.3. 15.9By Generation
15.10.4. By Scaffold Type
15.10.5. By Application
15.10.6. By End-user
15.10.7. By Country/Sub-region
16. Latin America Drug-eluting Stents Market Analysis and Forecast
16.1. Introduction
16.2. Key Findings
16.3. Latin America Drug-eluting Stents Market Value Forecast, by Product, 2017–2027
16.3.1. Polymer-based
16.3.1.1. Biodegradable Polymers
16.3.1.2. Durable Polymers
16.3.2. Polymer-free
16.4. Latin America Drug-eluting Stents Market Value Forecast, by Drug, 2017–2027
16.4.1. Sirolimus
16.4.2. Paclitaxel
16.4.3. Zotarolimus
16.4.4. Everolimus
16.4.5. Biolimus
16.4.6. Others
16.5. Latin America Drug-eluting Stents Market Value Forecast, by Generation, 2017–2027
16.5.1. 1st Generation
16.5.2. 2nd Generation
16.5.3. 3rd Generation
16.5.4. 4th Generation
16.6. Latin America Drug-eluting Stents Market Value Forecast, by Scaffold Type, 2017–2027
16.6.1. Cobalt Chromium
16.6.2. Platinum Chromium
16.6.3. Nitinol
16.6.4. Biodegradable
16.6.5. Others
16.7. Latin America Drug-eluting Stents Market Value Forecast, by Application, 2017–2027
16.7.1. Coronary Diseases
16.7.2. Peripheral Vascular Diseases
16.8. Latin America Drug-eluting Stents Market Value Forecast, by End-user, 2017–2027
16.8.1. Hospitals
16.8.2. Ambulatory Surgical Centers
16.9. Latin America Drug-eluting Stents Market Value Forecast, by Country/Sub-region, 2017–2027
16.9.1. Brazil
16.9.2. Mexico
16.9.3. Rest of Latin America
16.10. Latin America Drug-eluting Stents Market Attractiveness Analysis
16.10.1. By Product
16.10.2. By Drug
16.10.3. By Generation
16.10.4. By Scaffold Type
16.10.5. By Application
16.10.6. By End-user
16.10.7. By Country/Sub-region
17. Middle East & Africa Drug-eluting Stents Market Analysis and Forecast
17.1. Introduction
17.2. Key Findings
17.3. Middle East & Africa Drug-eluting Stents Market Value Forecast, by Product, 2017–2027
17.3.1. Polymer-based
17.3.1.1. Biodegradable Polymers
17.3.1.2. Durable Polymers
17.3.2. Polymer-free
17.4. Middle East & Africa Drug-eluting Stents Market Value Forecast, by Drug, 2017–2027
17.4.1. Sirolimus
17.4.2. Paclitaxel
17.4.3. Zotarolimus
17.4.4. Everolimus
17.4.5. Biolimus
17.4.6. Others
17.5. Middle East & Africa Drug-eluting Stents Market Value Forecast, by Generation, 2017–2027
17.5.1. 1st Generation
17.5.2. 2nd Generation
17.5.3. 3rd Generation
17.5.4. 4th Generation
17.6. Middle East & Africa Drug-eluting Stents Market Value Forecast, by Scaffold Type, 2017–2027
17.6.1. Cobalt Chromium
17.6.2. Platinum Chromium
17.6.3. Nitinol
17.6.4. Biodegradable
17.6.5. Others
17.7. Middle East & Africa Drug-eluting Stents Market Value Forecast, by Application, 2017–2027
17.7.1. Coronary Diseases
17.7.2. Peripheral Vascular Diseases
17.8. Market Value Forecast, by End-user, 2017–2027
17.8.1. Hospitals
17.8.2. Ambulatory Surgical Centers
17.9. Market Value Forecast, by Country/Sub-region, 2017–2027
17.9.1. GCC Countries
17.9.2. South Africa
17.9.3. Rest of Middle East & Africa
17.10. Middle East & Africa Drug-eluting Stents Market Attractiveness Analysis
17.10.1. By Product
17.10.2. By Drug
17.10.3. By Generation
17.10.4. By Scaffold Type
17.10.5. By Application
17.10.6. By End-user
17.10.7. By Country/Sub-region
18. Competition Landscape
18.1. Market Player – Competition Matrix (By Tier and Size of companies)
18.2. Market Share Analysis by Company (2018)
18.3. Company Profiles
18.3.1. Boston Scientific Corporation
18.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.1.2. Financial Overview
18.3.1.3. Product Portfolio
18.3.1.4. SWOT Analysis
18.3.1.5. Strategic Overview
18.3.2. Medtronic
18.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.2.2. Financial Overview
18.3.2.3. Product Portfolio
18.3.2.4. SWOT Analysis
18.3.2.5. Strategic Overview
18.3.3. Abbott
18.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.3.2. Financial Overview
18.3.3.3. Product Portfolio
18.3.3.4. SWOT Analysis
18.3.3.5. Strategic Overview
18.3.4. Biosensors International Group, Ltd (Bluesail Medical Co., Ltd.)
18.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.4.2. Product Portfolio
18.3.4.3. SWOT Analysis
18.3.4.4. Strategic Overview
18.3.5. Biotronik
18.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.5.2. Product Portfolio
18.3.5.3. SWOT Analysis
18.3.5.4. Strategic Overview
18.3.6. MicroPort Scientific Corporation
18.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.6.2. Financial Overview
18.3.6.3. Product Portfolio
18.3.6.4. SWOT Analysis
18.3.6.5. Strategic Overview
18.3.7. Terumo Corporation
18.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.7.2. Financial Overview
18.3.7.3. Product Portfolio
18.3.7.4. SWOT Analysis
18.3.7.5. Strategic Overview
18.3.8. Cook
18.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.8.2. Product Portfolio
18.3.8.3. SWOT Analysis
18.3.8.4. Strategic Overview
18.3.9. STENTYS SA
18.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.9.2. Financial Overview
18.3.9.3. Product Portfolio
18.3.9.4. SWOT Analysis
18.3.9.5. Strategic Overview
18.3.10. Medinol Ltd
18.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
18.3.10.2. Product Portfolio
18.3.10.3. SWOT Analysis
18.3.10.4. Strategic Overview

List of Tables

Table 01 Regulatory Approvals in Drug-eluting Stents Market (1/2)
Table 02 Regulatory Approvals in Drug-eluting Stents Market (2/2)
Table 03 Product Launch in Drug-eluting Stents Market
Table 04 Global Drug-eluting Stents Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 05 Global Drug-eluting Stents Market Value (US$ Mn) Forecast, by Polymer-based Type, 2017–2027
Table 06 Global Drug-eluting Stents Market Value (US$ Mn) Forecast, by Drug, 2017–2027
Table 07 Global Drug-eluting Stents Market Value (US$ Mn) Forecast, by Generation, 2017–2027
Table 08 Global Drug-eluting Stents Market Value (US$ Mn) Forecast, by Scaffold, 2017–2027
Table 09 Global Drug-eluting Stents Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 10 Global Drug-eluting Stents Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 11 Global Drug-eluting Stents Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 12 North America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 13 North America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Polymer-based Type, 2017–2027
Table 14 North America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Drug, 2017–2027
Table 15 North America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Generation, 2017–2027
Table 16 North America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Scaffold, 2017–2027
Table 17 North America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 18 North America Drug-eluting Stents Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 19 North America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 20 Europe Drug-eluting Stents Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 21 Europe Drug-eluting Stents Market Value (US$ Mn) Forecast, by Polymer-based Type, 2017–2027
Table 22 Europe Drug-eluting Stents Market Value (US$ Mn) Forecast, by Drug, 2017–2027
Table 23 Europe Drug-eluting Stents Market Value (US$ Mn) Forecast, by Generation, 2017–2027
Table 24 Europe Drug-eluting Stents Market Value (US$ Mn) Forecast, by Scaffold, 2017–2027
Table 25 Europe Drug-eluting Stents Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 26 Europe Drug-eluting Stents Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 27 Europe Drug-eluting Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 28 Asia Pacific Drug-eluting Stents Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 29 Asia Pacific Drug-eluting Stents Market Value (US$ Mn) Forecast, by Polymer-based Type, 2017–2027
Table 30 Asia Pacific Drug-eluting Stents Market Value (US$ Mn) Forecast, by Drug, 2017–2027
Table 31 Asia Pacific Drug-eluting Stents Market Value (US$ Mn) Forecast, by Generation, 2017–2027
Table 32 Asia Pacific Drug-eluting Stents Market Value (US$ Mn) Forecast, by Scaffold, 2017–2027
Table 33 Asia Pacific Drug-eluting Stents Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 34 Asia Pacific Drug-eluting Stents Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 35 Asia Pacific Drug-eluting Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 36 Latin America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 37 Latin America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Polymer-based Type, 2017–2027
Table 38 Latin America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Drug, 2017–2027
Table 39 Latin America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Generation, 2017–2027
Table 40 Latin America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Scaffold, 2017–2027
Table 41 Latin America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 42 Latin America Drug-eluting Stents Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 43 Latin America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 44 Middle East & Africa Drug-eluting Stents Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 45 Middle East & Africa Drug-eluting Stents Market Value (US$ Mn) Forecast, by Polymer-based Type, 2017–2027
Table 46 Middle East & Africa Drug-eluting Stents Market Value (US$ Mn) Forecast, by Drug, 2017–2027
Table 47 Middle East & Africa Drug-eluting Stents Market Value (US$ Mn) Forecast, by Generation, 2017–2027
Table 48 Middle East & Africa Drug-eluting Stents Market Value (US$ Mn) Forecast, by Scaffold, 2017–2027
Table 49 Middle East & Africa Drug-eluting Stents Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 50 Middle East & Africa Drug-eluting Stents Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 51 Middle East & Africa Drug-eluting Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027